Leave Your Message

Sustainable rFC Endotoxin Assay Kit: Reliable BET Solution from China Suppliers and Factory

,

The rFC Endotoxin Assay Kit is a cutting-edge solution for bacterial endotoxin testing (BET), leveraging the recombinant Factor C (rFC) fluorometric method as a contemporary alternative to traditional Limulus Amebocyte Lysate (LAL) assays. This innovative kit is particularly valuable for China suppliers in pharmaceuticals, medical devices, and biologics.

,

Endotoxins, which are lipopolysaccharides released from the outer membranes of Gram-negative bacteria, represent significant risks in the production of safe pharmaceutical products. As a result, precise detection is crucial for manufacturers and quality control processes.

,

This assay kit utilizes genetically modified recombinant Factor C (rFC), a vital protein initially derived from horseshoe crab hemolymph, to accurately identify endotoxins. When endotoxins are present, rFC activates a cascade that hydrolyzes a fluorogenic substrate, generating a fluorescent signal. The intensity of this fluorescence, measured by a fluorescence microplate, directly correlates with the endotoxin concentration, allowing for precise quantitative analysis.

,

The rFC Endotoxin Assay Kit features numerous advantages, such as high specificity—effectively eliminating cross-reactivity with β-1,3-glucans, which is a common drawback of LAL assays. Additionally, it promotes sustainability by avoiding the need to harvest horseshoe crabs. This reliable testing method aligns with global pharmacopeial standards, including USP and EP regulations. As a trusted choice among China suppliers, this kit is widely adopted for pharmaceutical quality control, biomedical research, and medical device validation, ensuring the safety of products.

,

    Technical Information on Recombinant Factor C (rFC) Fluorometric Assay for Bacterial Endotoxin Detection

    The rFC fluorometric assay is a horseshoe crab-free, in vitro method for quantitative bacterial endotoxin (lipopolysaccharide, LPS) detection, compliant with global pharmacopoeias (USP <85>, EP 2.6.14). Its core principle relies on recombinant Factor C (rFC)—a recombinant protein engineered from the LPS-binding domain of horseshoe crab Factor C—eliminating reliance on natural horseshoe crab blood and addressing sustainability concerns.

    1. Assay Principle

    Endotoxin LPS specifically binds to the LPS-recognition domain of rFC, triggering a conformational change that activates rFC’s serine protease activity. The intensity of AMC fluorescence is directly proportional to the endotoxin concentration in the sample, measurable via a fluorescence microplate reader.

    2. Key Technical Parameters

    • Sensitivity: Detects endotoxins at concentrations as low as 0.005 EU/mL, matching or exceeding traditional Limulus Amebocyte Lysate (LAL) assays.
    • Linear Range: Typically covers 0.005–50 EU/mL, enabling quantitative analysis across a broad concentration spectrum.
    • Specificity: Exhibits high specificity for LPS; it is not activated by (1→3)-β-D-glucans (a common interference in LAL gel-clot assays), reducing false-positive results.
    • Incubation Conditions: Requires controlled temperature (37±1°C) and incubation time (60–120 minutes), with fluorescence measured at excitation/emission wavelengths of ~360 nm/~460 nm.

    3. Workflow Overview

    • Prepare samples (e.g., pharmaceuticals, medical devices, biological products) via dilution or extraction to remove matrix interference.
    • Mix rFC reagent, fluorogenic substrate, and sample in a microplate well.
    • Incubate at 37°C to allow LPS-rFC binding, activation, and substrate cleavage.
    • Measure fluorescence intensity; calculate endotoxin concentration using a standard curve generated with known endotoxin standards (e.g., Escherichia coli O55:B5 LPS).

    This assay combines sustainability (no horseshoe crab harvesting), reliability (low interference, high reproducibility), and efficiency, making it ideal for quality control in pharmaceutical and biotech industries.

    Frequently Asked Questions (FAQ)

    What is the core difference between the rFC assay and traditional LAL assays?
    The rFC assay is a horseshoe crab-free, in vitro method utilizing a recombinant protein engineered from the LPS-binding domain of horseshoe crab Factor C. Unlike traditional LAL assays, it does not rely on natural horseshoe crab blood, making it a sustainable and ecologically friendly solution.
    Is the rFC fluorometric assay compliant with international pharmacopoeias?
    Yes, the rFC fluorometric assay is compliant with global pharmacopoeial standards, including USP <85> and EP 2.6.14, for quantitative bacterial endotoxin detection.
    How sensitive is the rFC assay compared to LAL?
    The rFC assay is highly sensitive, detecting endotoxins at concentrations as low as 0.005 EU/mL. This sensitivity matches or exceeds that of traditional Limulus Amebocyte Lysate (LAL) assays.
    Does the rFC assay suffer from false positives due to beta-glucans?
    No. The rFC assay exhibits high specificity for LPS and is not activated by (1→3)-β-D-glucans, which are a common source of interference and false-positive results in traditional LAL gel-clot assays.
    What are the required incubation and measurement conditions?
    The assay requires a controlled incubation temperature of 37±1°C for 60–120 minutes. The resulting fluorescence is measured using a microplate reader at excitation/emission wavelengths of approximately 360 nm and 460 nm.